This article is a correction to:
LncRNA NBR2 Inhibits the Malignancy of Thyroid Cancer, Associated With Enhancing the AMPK Signaling
Wen Yang
Zhikun Zheng
Pengfei Yi
Shi Wang
Ning Zhang
Jie Ming
Jie Tan
Hui Guo- 1Department of Breast and Thyroid Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
- 2Department of Thoracic Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
A Corrigendum on
LncRNA NBR2 Inhibits the Malignancy of Thyroid Cancer, Associated With Enhancing the AMPK Signaling
By Yang W, Zheng Z, Yi P, Wang S, Zhang N, Ming J, Tan J and Guo H (2020). Front. Oncol. 10:956. doi: 10.3389/fonc.2020.00956
In the published article, the co-first authors are three people including the corresponding author Hui Guo, but in fact the co-first authors should be Wen Yang and Zhikun Zheng. Hui Guo is the corresponding author but not the co-first author, so the symbol “†” behind Hui Guo’s name is deleted.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s Note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: LncRNA NBR2, thyroid cancer, malignancy, AMPK, EMT
Citation: Yang W, Zheng Z, Yi P, Wang S, Zhang N, Ming J, Tan J and Guo H (2021) Corrigendum: LncRNA NBR2 Inhibits the Malignancy of Thyroid Cancer, Associated With Enhancing the AMPK Signaling. Front. Oncol. 11:759471. doi: 10.3389/fonc.2021.759471
Received: 16 August 2021; Accepted: 17 August 2021;
Published: 27 August 2021.
Copyright © 2021 Yang, Zheng, Yi, Wang, Zhang, Ming, Tan and Guo. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Hui Guo, guohuihust@163.com
†These authors have contributed equally to this work